Literature DB >> 15579723

Exacerbations and time spent outdoors in chronic obstructive pulmonary disease.

Gavin C Donaldson1, Tom M A Wilkinson, John R Hurst, Wayomi R Perera, Jadwiga A Wedzicha.   

Abstract

Patients with chronic obstructive pulmonary disease have a progressive reduction in activity, although its time scale and the contribution of exacerbations are unknown. A rolling cohort of 147 patients (101 male; mean age, 88.5 years; and forced expiratory volume in 1 second as percent predicted, 38.4%) were monitored for a median of 1,044 days (interquartile range, 685 to 1,779) over an 8-year period starting in March 1996. Patients recorded any increase in daily respiratory symptoms and time spent outside their home. They completed the St. George's Respiratory Questionnaire yearly. They experienced 1,465 exacerbations and time outdoors decreased by -0.16 hours/day per year (p < 0.001). This decline was faster in frequent exacerbators (p = 0.011). Before exacerbation, the patients stayed indoors all day for 2.1 days/week (on any day 34.1% were at home), but for 5 weeks postexacerbation they spent 2.5 days/week at home (p < 0.001) (44.4% remaining at home at onset; p = 0.021). St. George's total, activity, and impact scores were independently associated with time outdoors (p < 0.005), but not with symptom score. In conclusion, time spent outside the home declines over time and acutely at exacerbation. Patients with frequent exacerbations are more likely to become housebound and need targeting in rehabilitation programs.

Entities:  

Mesh:

Year:  2004        PMID: 15579723     DOI: 10.1164/rccm.200408-1054OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  87 in total

Review 1.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

2.  Accuracy of uniaxial accelerometer in chronic obstructive pulmonary disease.

Authors:  Marilyn L Moy; Eric Garshick; Kirby R Matthess; Robert Lew; John J Reilly
Journal:  J Rehabil Res Dev       Date:  2008

3.  Long-Term Evaluation of the Effects of Aclidinium Bromide on Major Adverse Cardiovascular Events and COPD Exacerbations in Patients with Moderate to Very Severe COPD: Rationale and Design of the ASCENT COPD Study.

Authors:  Robert A Wise; Kenneth R Chapman; Benjamin M Scirica; David A Schoenfeld; Deepak L Bhatt; Sami Z Daoud; Beatriz Seoane; Colin Reisner; Esther Garcia Gil
Journal:  Chronic Obstr Pulm Dis       Date:  2018-01-24

4.  Utility estimation in chronic obstructive pulmonary disease: a preference for change?

Authors:  Jennifer Petrillo; Floortje van Nooten; Paul Jones; Maureen Rutten-van Mölken
Journal:  Pharmacoeconomics       Date:  2011-11       Impact factor: 4.981

5.  Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease. What We Know and Can Do for Our Patients.

Authors:  Ariel Jaitovich; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2018-07-15       Impact factor: 21.405

6.  Domiciliary pulse-oximetry at exacerbation of chronic obstructive pulmonary disease: prospective pilot study.

Authors:  John R Hurst; Gavin C Donaldson; Jennifer K Quint; James J P Goldring; Anant R C Patel; Jadwiga A Wedzicha
Journal:  BMC Pulm Med       Date:  2010-10-20       Impact factor: 3.317

Review 7.  The role of NIV in chronic hypercapnic COPD following an acute exacerbation: the importance of patient selection?

Authors:  Marieke L Duiverman; Wolfram Windisch; Jan H Storre; Peter J Wijkstra
Journal:  Ther Adv Respir Dis       Date:  2016-01-08       Impact factor: 4.031

8.  Assessment of a primary and tertiary care integrated management model for chronic obstructive pulmonary disease.

Authors:  Ignasi Bolíbar; Vicente Plaza; Mariantònia Llauger; Ester Amado; Pedro A Antón; Ana Espinosa; Leandra Domínguez; Mar Fraga; Montserrat Freixas; Josep A de la Fuente; Iskra Liguerre; Casimira Medrano; Meritxell Peiro; Mariantònia Pou; Joaquin Sanchis; Ingrid Solanes; Carles Valero; Pepi Valverde
Journal:  BMC Public Health       Date:  2009-02-24       Impact factor: 3.295

Review 9.  Strategies for improving outcomes of COPD exacerbations.

Authors:  Tom Wilkinson; J A Wedzicha
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006

10.  Impact of patient characteristics, education and knowledge on emergency room visits in patients with asthma and COPD: a descriptive and correlative study.

Authors:  Margareta Emtner; Anna Hedin; Mikael Andersson; Christer Janson
Journal:  BMC Pulm Med       Date:  2009-09-07       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.